Faruqi & Faruqi, LLP Announces Investigation Of TranS1 Inc.
NEW YORK, Jan. 25, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at TranS1 Inc. ("TranS1" or the "Company") (Nasdaq: TSON).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) TranS1 was not in compliance with the U.S. government's healthcare fraud and false claim statutes; (2) the Company was engaged in improper reimbursement practices; and (3) TranS1 lacked adequate internal and financial controls for its business.Request more information now by clicking here: www.faruqilaw.com/TSON Take Action If you purchased TranS1 securities between February 21, 2008 and October 17, 2011 and would like to discuss your legal rights, visit www.faruqilaw.com/TSON. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding TranS1 conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter.FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor New York, NY 10017Attn: Richard Gonnello, Esq. email@example.com Francis McConville, Esq. firstname.lastname@example.org Telephone: (877) 247-4292 or (212) 983-9330 SOURCE Faruqi & Faruqi, LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts